Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| PIM1-IN-7 | C23H23N5O | 2439168-72-4 | Details |
| PPARγ agonist 3 | C24H23N3O | 2011801-48-0 | Details |
| NMDA receptor antagonist 5 | C19H16BrNO2 | 2415998-36-4 | Details |
| Tyrosinase-IN-3 | C21H23NO5 | 2409081-40-7 | Details |
| NHE3-IN-3 | C16H16Cl2N2O2S | 543734-50-5 | Details |
| EV-A71-IN-1 | C21H15N5S | 2413648-96-9 | Details |
| EGFR-IN-51 | C21H15N3O2S | 2418549-32-1 | Details |
| S07-2010 | C19H21N3O3S | 1223194-71-5 | Details |
| S07-2005 (racemic) | C20H23NO6 | 1826337-40-9 | Details |
| Antitubercular agent-24 | C18H19N3O2S2 | 1845719-43-8 | Details |
| 5-HT2A receptor agonist-2 | C20H21ClN2O3 | 528525-37-3 | Details |
| AAK1-IN-4 | C20H28N4O3 | 1815612-79-3 | Details |
| Anticancer agent 37 | C19H19N3O3S | 905783-28-0 | Details |
| 5-HT7 receptor ligand 1 | C21H23N7 | 2758571-64-9 | Details |
| ASIC-IN-1 | C23H25N3O2 | 308088-10-0 | Details |
| piCRAC-1 | C17H10F6N4 | 2418049-54-2 | Details |
| FGFR-IN-7 | C16H21ClF2N4O2 | 2488764-17-4 | Details |
| PKM2 activator 3 | C15H11ClF2N2O3S | 1346113-84-5 | Details |
| A1AR antagonist 4 | C23H25N3O2 | 1031993-35-7 | Details |
| Tubulin/HDAC-IN-1 | C21H18N4O3 | 2413587-26-3 | Details |
| NPR-C activator 1 | C18H24N6O3 | 2768328-61-4 | Details |
| Autophagy inducer 3 | C24H43NO2 | 2691054-63-2 | Details |
| Antifungal agent 32 | C25H28N2O | 1809167-48-3 | Details |
| Anticancer agent 57 | C20H21Cl2NO2 | 2408017-71-8 | Details |
| TP0480066 | C18H14FN3O5 | 2245693-15-4 | Details |
| AKT-IN-5 | C23H20N4O2 | 1402608-05-2 | Details |
| ASK1-IN-3 | C18H18N8O2 | 2426705-19-1 | Details |
| Tubulin polymerization-IN-13 | C20H21NO6 | 2426665-56-5 | Details |
| DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
| GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
| SARS-CoV-2-IN-17 | C19H19F3N2O3 | 2761911-44-6 | Details |
| TGFβ-IN-2 | C22H22N2O4 | 2387678-02-4 | Details |
| SUN13837 | C21H29N5O2 | 1080650-67-4 | Details |
| MAT2A-IN-7 | C17H13ClF3N3O2 | 2756458-77-0 | Details |
| BChE-IN-4 | C24H37N3O | 2304818-41-3 | Details |
| hCAI/II-IN-4 | C15H15N3O5S2 | 2480284-01-1 | Details |
| HIF-2α-IN-5 | C15H12F4O3S2 | 2388500-66-9 | Details |
| EGFR-IN-57 | C22H15N3O2S | 2492382-37-1 | Details |
| GLUT4-IN-2 | C17H11N3O4S2 | 2454113-83-6 | Details |
| COX-2/5-LOX-IN-1 | C14H10ClN3O4S2 | 2410384-50-6 | Details |
| O-GlcNAcase-IN-4 | C16H22FN5O3S | 2241514-58-7 | Details |
| Polyketide synthase 13-IN-2 | C22H21NO5 | 2219338-48-2 | Details |
| GABAA receptor agent 5 | C21H25N3O2S | 1808389-92-5 | Details |
| Anticancer agent 56 | C20H18ClN3O3 | 2241915-59-1 | Details |
| GPVI antagonist 1 | C19H19N3O4S | 1327156-14-8 | Details |
| TK4g | C19H19N3O4S | 2232890-86-5 | Details |
| FGFR-IN-3 | C18H27F2N5O2 | 2488762-63-4 | Details |
| Falcipain-2/3-IN-2 | C21H23N3O4 | 946209-23-0 | Details |
| DNA-PK-IN-2 | C20H23N5O3 | 2665720-22-7 | Details |
| SARS-CoV-2-IN-20 | C24H30N2O2 | 1260244-33-4 | Details |
| Influenza A virus-IN-4 | C19H28N4O4 | 2390067-58-8 | Details |
| MMV687807 | C15H8ClF6NO2 | 1417658-11-7 | Details |
| Nampt-IN-7 | C20H21N5O3 | 1223378-42-4 | Details |
| ATR-IN-15 | C19H22N8O | 2756665-52-6 | Details |
| Anti-inflammatory agent 8 | C18H15N5OS2 | 1103920-19-9 | Details |
| 11β-HSD1-IN-6 | C21H19ClN4O | 1303515-33-4 | Details |
| S1P1 agonist 4 | C24H31NO3 | 1883345-11-6 | Details |
| KDM5B-IN-3 | C19H25ClN4O2 | 1385101-10-9 | Details |
| PARP1-IN-10 | C20H23N3O5 | 2494001-21-5 | Details |
| HBV-IN-21 | C17H17FN4OS2 | 2460957-52-0 | Details |
| Mt KARI-IN-2 | C14H11N5O4S2 | 2413974-52-2 | Details |
| 4-Piperidinecarboxamide | C16H15Cl2N3O2S | 519034-65-2 | Details |
| Antiparasitic agent-5 | C20H16ClN3O3 | 2494276-55-8 | Details |
| CSF1R-IN-13 | C21H20N4O3 | 2361556-61-6 | Details |
| HSV-1/HSV-2-IN-2 | C17H14ClFN4OS | 2490468-39-6 | Details |
| AM-1488 | C19H17N3O4S | 2079895-60-4 | Details |
| ATP synthase inhibitor 2 | C21H22N2O3S | 2814540-76-4 | Details |
| VPC-13789 | C21H16F3N3O | 2761146-51-2 | Details |
| FTase-IN-1 | C23H16N2O2S | 2490538-41-3 | Details |
| Aldose reductase-IN-6 | C20H16N4O2S | 2470019-41-9 | Details |
| Tubulin polymerization-IN-10 | C18H21NO6S | 2238784-19-3 | Details |
| IMMH001 | C23H28N2O3 | 1418093-75-0 | Details |
| Steroid sulfatase-IN-1 | C14H10Cl2N4O3S | 2403716-19-6 | Details |
| ATG7-IN-2 | C11H16N6O7S | 2226227-75-2 | Details |
| CXCR4 antagonist 9 | C21H27FN6 | 2304750-83-0 | Details |
| ThrRS-IN-1 | C16H18Cl2N4O3 | 2408626-64-0 | Details |
| Antitumor agent-38 | C22H24N2O4 | 2744193-34-6 | Details |
| AAK1-IN-5 | C19H23F4N3O | 1815613-44-5 | Details |
| EGFR-IN-52 | C19H18N4O3S | 454436-75-0 | Details |
| Myt1-IN-2 | C18H16N6O2S | 2719748-43-1 | Details |
| ANO1-IN-2 | C16H14ClN3O2S2 | 637314-12-6 | Details |
| CD73-IN-6 | C20H15N7O2 | 2757808-96-9 | Details |
| mEH-IN-1 | C16H17F6NOS | 2418576-06-2 | Details |
| PKC-IN-4 | C21H25N5S | 2636771-29-2 | Details |
| Antitumor agent-53 | C24H18FN3O | 2757145-67-6 | Details |
| ERK5-IN-4 | C16H11Cl2FN4O2 | 1888305-17-6 | Details |
| ATR-IN-19 | C18H19N7OS | 2648989-61-9 | Details |
| Trk-IN-20 | C22H18F2N4 | 2460924-63-2 | Details |
| HDAC-IN-42 | C20H15NO7 | 2454024-18-9 | Details |
| ATG7-IN-3 | C11H16N6O5S2 | 2226229-76-9 | Details |
| TYK2-IN-11 | C18H17N5O3S | 2757009-40-6 | Details |
| Antiparasitic agent-9 | C18H20N6O2S | 2516237-50-4 | Details |
| SK3 Channel-IN-1 | C25H49NO | 2396571-04-1 | Details |
| Steroid sulfatase-IN-3 | C17H21ClN2O4S | 2413880-53-0 | Details |
| CB1-IN-2 | C17H19Cl2N5O | 2527805-39-4 | Details |
| Antibacterial agent 106 | C20H24N6S | 2459657-11-3 | Details |
| DMX-129 | C19H17FN8 | 1623123-95-4 | Details |
| VEGFR-2-IN-23 | C22H15N5O2 | 2411174-53-1 | Details |
| c-ABL-IN-3 | C17H11F3N4O3 | 2626934-64-1 | Details |
| Anti-inflammatory agent 22 | C22H16O6 | 2721484-76-8 | Details |
| Product Total： Product Page： | ||||
| 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 | ||||